TY  - GEN
AU  - Marin,D
AU  - Gabriel,I H
AU  - Ahmad,S
AU  - Foroni,L
AU  - de Lavallade,H
AU  - Clark,R
AU  - O'Brien,S
AU  - Sergeant,R
AU  - Hedgley,C
AU  - Milojkovic,D
AU  - Khorashad,J S
AU  - Bua,M
AU  - Alsuliman,A
AU  - Khoder,A
AU  - Stringaris,K
AU  - Cooper,N
AU  - Davis,J
AU  - Goldman,J M
AU  - Apperley,J F
AU  - Rezvani,K
TI  - KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib
SN  - 1476-5551
PY  - 2012///0330
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Benzamides
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Pyrimidines
KW  - Receptors, KIR
KW  - genetics
KW  - Remission Induction
KW  - Survival Analysis
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
UR  - https://doi.org/10.1038/leu.2011.180
ER  -